Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments (Tables)

v3.20.1
Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2020
Fair Value Disclosures [Abstract]  
Fair Value, by Balance Sheet Grouping The composition of financial instruments is as follows:
March 31, 2020 December 31, 2019
(in thousands)
Liabilities
Interest rate swap $ 231    $ 37   
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following table presents a summary of the Company’s financial instruments that are measured on a recurring basis:
Fair Value Measurements
Balance Quoted Prices
in Active Markets for Identical Assets
(Level 1)
Significant Other
Observable Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
(in thousands)
Liabilities
Interest rate swap, March 31, 2020 $ 231    $ —    $ 231    $ —   
Interest rate swap, December 31, 2019 $ 37    $ —    $ 37    $ —   
Derivative Instruments and Hedging Activities Disclosure
The following table summarizes activity for the interest rate swap:
Three Months Ended
March 31,
2020
March 31,
2019
(in thousands)
Interest rate swap asset (liability)
Beginning balance $ (37)   $ 1,623   
Unrealized loss recognized in other comprehensive income (loss) (194)   (618)  
Ending balance $ (231)   $ 1,005